Aussie Fantasy Press Release Time: ANTG announces merger with Asterion to build $400m medicinal cannabis facility and create 1,000 jobs in QLD

They might as well have said a million jobs !

We highlight as key points some of the usual language that always makes us wary

At the very end the final sentence reads “A partially binding agreement Letter of Intent has been signed by both parties.”

We say we’ll believe these numbers when we actually see it. Plus note they say they say they will create 1000 regional jobs which of course implies in reality that they won’t be employing a 1000 people but it will magic those 1000 jobs into existence  “500,000kg of medicinal cannabis a year and create 1,000 regional jobs.”

From Asterion some wonderful corporate speak that we so enjoy here at CLR .. “Asterion CEO Stephen Van Deventer said: “The merger of Asterion and ANTG fits in with both companies’ short and long-term strategies. This provides early revenue for Asterion and scalability to ANTG. We are extremely excited with this merger as both companies have the same vision, priorities and mindset.”

 

Cannabiz reports..

Australian Natural Therapeutics Group (ANTG) has announced a merger with Canadian Asterion Cannabis and its wholly-owned subsidiary Asterion (Australia), with the companies joining forces to develop one of the largest renewable-powered medicinal cannabis growing, manufacturing and R&D facilities in the world.

Construction on the A$400 million facility in the Darling Downs, near Toowoomba, is scheduled to begin in the next few months, with the 75 hectare facility set to produce more than 500,000kg of medicinal cannabis a year and create 1,000 regional jobs.

ANTG CEO Matt Cantelo said the agreement represents a “golden opportunity” for Australia to reach its full potential in growing and cultivating medicinal cannabis, serving the domestic and export markets and becoming the global leader in medicinal cannabis production.

ANTG CEO Matt Cantelo

Cantelo, who earlier this year signed a $92 million, nine-year deal with German company Cannamedical Pharma to export commercially-grown Australian medical cannabis flowers to Europe, added: “We have the gold standard in regulatory framework, depth of research and climate for growing excellent produce – but what we haven’t had to date is the option of scale.”

“This has meant we could mostly meet the demand to the general market, but in the coming years we see demand will absolutely outstrip supply.”

“Through this new partnership we will be able to expand our range to meet the growing number of conditions being prescribed by doctors.”

Asterion CEO Stephen Van Deventer said: “The merger of Asterion and ANTG fits in with both companies’ short and long-term strategies. This provides early revenue for Asterion and scalability to ANTG. We are extremely excited with this merger as both companies have the same vision, priorities and mindset.”

The first 10 hectare glasshouse and manufacturing facility is due to be operational by the end of next year, with two more 10 and 20 hectare glasshouses planned after that.

Well-situated in close proximity to Toowoomba’s Wellcamp Airport, the facility will have easy access to international routes and markets.

A partially binding agreement Letter of Intent has been signed by both parties.

Source:  https://www.cannabiz.com.au/antg-announces-merger-with-asterion-to-build-400m-medicinal-cannabis-facility-and-create-1000-jobs-in-qld/

Primary Sponsor

Cannabis Banking - FinCann

New: Free USA Cannabis Case Law Search – New Cases Daily

Directory Categories

Karma Koala Podcast

Sponsor – aBizinaBox

Top Marijuana Blog
%d bloggers like this: